11 completed, 7 recruiting, 2 not yet recruiting, 2 unknown. 8 Not applicable, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 4, Not yet recruiting 2, Recruiting 2 |
| Phase 4 | 2 | Withdrawn 2 |
Follow HeartFlow, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care Heartflow Analysis - CAD - Coronary Artery Disease | Not applicable | Not yet recruiting | HeartFlow, Inc. | 500 | 2026-11-01 | 2026-10-02 |
| REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease Heartflow Analysis - CAD - Coronary Artery Disease | Not applicable | Not yet recruiting | HeartFlow, Inc. | 350 | 2026-10-01 | 2026-09-22 |
| Coronary Computed Tomography Angiography (CCTA) for the Pre-procedural Planning of Percutaneous Coronary Intervention CT-guided PCI, Routine PCI - Coronary Artery Disease, CT | Not applicable | Recruiting | Minneapolis Heart Institute Foundation | 200 | 2026-08-31 | 2026-08-27 |
| The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI Heartflow PCI Navigator - Coronary Artery Disease (CAD) | Recruiting | HeartFlow, Inc. | 5000 | 2026-03-11 | 2026-03-23 | |
| Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT Rosuvastatin 40mg, Placebo, Coronary Computed Tomography Angiography (Coronary CTA) - Coronary Artery Disease, Atherosclerotic Plaque | Not applicable | Recruiting | Prof. Maurovich-Horvat Pál | 140 | 2025-05-28 | 2026-05-13 |
| Risk Characterization of Non-culprit Vessels in Patients Undergoing Primary PCI for ST-elevation MI in Multivessel Disease CT Coronary Angiography - ST Elevation Myocardial Infarction | Recruiting | University Hospital Southampton NHS Foundation Trust | 320 | 2025-01-20 | 2025-09-23 | |
| Using CTA Measures to Define Cardiac Risk In NFL Alumni Coronary computed tomography angiography - Coronary Artery Disease (CAD), Heart Disease | Recruiting | HeartFlow, Inc. | 300 | 2024-12-17 | 2025-08-26 | |
| AI DErived Plaque Quantification: CCTA and AI-QCPA for Determining Effective CAD Management AI-enabled quantitative coronary plaque analysis (AI-QCPA) - Coronary Artery Disease | Active not recruiting | HeartFlow, Inc. | 20000 | 2024-03-27 | 2026-09-15 | |
| The COMPLETE Study Coronary Artery Disease | Recruiting | CoreAalst BV | 250 | 2023-10-24 | 2026-01-20 | |
| Assessing Diagnostic Value of Non-invasive FFR-CT in Coronary Care in the Emergency Department FFR-CT - Coronary Artery Disease | Terminated | HeartFlow, Inc. | 18 | 2022-07-15 | 2026-05-22 | |
| The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA Total Plaque Volume - Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Completed | HeartFlow, Inc. | 258 | 2021-10-12 | 2025-08-22 | |
| DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR Type 2 Myocardial Infarction | Completed | Massachusetts General Hospital | 50 | 2021-04-11 | 2024-03-13 | |
| CMR Versus CT in Coronary Artery Disease CMR and CTCA with CT-FFR - Coronary Artery Disease | Recruiting | University of Leicester | 300 | 2020-11-05 | 2025-07-01 | |
| Safety and Feasibility Evaluation of Planning and Execution of Surgical Revascularization Solely Based on Coronary CTA and FFRCT in Patients With Complex Coronary Artery Disease (FASTTRACK CABG) Coronary computed tomography angiography - Coronary Artery Disease, Myocardial Ischemia | Unknown | National University of Ireland, Galway, Ireland | 114 | 2020-09-01 | 2022-04-26 | |
| Influence of Lipid Lowering on Impaired Coronary Flow High intensity lipid lowering - Coronary Artery Disease | Not applicable | Completed | Aarhus University Hospital | 109 | 2020-05-15 | 2025-04-03 |
| Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion Evolocumab - Coronary Artery Disease | Phase 4 | Withdrawn | ECRI bv | 2019-08-30 | 2019-12-06 | |
| A Multicentre, Pilot Study to Evaluate the Safety and the Feasibility of Planning and Execution of Surgical Revascularization in Patients With Complex Coronary Artery Disease, Based Solely on MSCT Imaging Utilizing GE Healthcare Revolution CT and HeartFlow FFRCT. Multi-sliced computed tomography (MSCT) - Multivessel Coronary Artery Disease | Phase 4 | Withdrawn | ECRI bv | 2019-06-28 | 2019-12-06 | |
| The PRECISE Protocol: Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization cCTA with selective FFRct - Coronary Artery Disease | Not applicable | Completed | HeartFlow, Inc. | 2103 | 2018-11-27 | 2023-12-29 |
| The Value of CT Fractional Flow Reserve HeartFLow CT-FFR - Angina, Stable Chest Pain | Completed | Northwell Health | 586 | 2017-01-01 | 2023-05-30 | |
| Comparisons of Morphological Measurement Between Coronary Computed Tomography and Optical Coherence Tomography data collection, non-intervention - Coronary Artery Disease | Completed | Kobe University | 72 | 2016-07-01 | 2017-01-13 |
Showing 20 of 26. Sign in to see all of them.
Coronary Artery Disease (21) · Heart Diseases (4) · Cardiovascular Diseases (3) · Angina Pectoris (2) · Arteriosclerosis (2) · Myocardial Infarction (2) · Myocardial Ischemia (2) · Plaque, Atherosclerotic (2) · Vascular Diseases (2) · Acute Coronary Syndrome (1) · Arterial Occlusive Diseases (1) · Coronary Disease (1) · Hyperlipidemias (1) · Inflammation (1) · Rupture, Spontaneous (1)
Clinical Laboratory Techniques (1) · Data Collection (1) · Hematologic Tests (1) · Rosuvastatin Calcium (1) · evolocumab (1)
United States (12) · Belgium (5) · Germany (4) · Italy (4) · Denmark (3) · United Kingdom (3) · France (2) · Switzerland (2) · Austria (1) · Hungary (1) · Japan (1) · South Korea (1)
Patrick W Serruys, Prof. dr. (2) · Bernard de Bruyne, MD, PHD (1) · Bjarne Norgaard, MD (1) · Bjarne Norgaard, MD, PhD (1) · Bon-Kwon Koo, MD, PhD (1) · Eric Wyffels, MD, PhD (1) · Gaku Nakazawa, MD (1) · Gianluca Pontone, MD (1) · Jagat Narula, MD (1) · James K Min, MD, FACC (1) · James L Januzzi, MD (1) · Jeffrey Boone (1) · Jonathon Leipsic, MD (1) · Joo Myung Lee, MD, MPH (1)
PMID 22922562, PMID 24268114, PMID 24486266, PMID 25592691, PMID 26444662, PMID 26475205, PMID 27470449, PMID 29550316, PMID 29866619, PMID 30312411, PMID 31005540, PMID 31184558, PMID 31335283, PMID 31833413, PMID 32861656, PMID 33303435, PMID 34953768, PMID 37610731, PMID 37610768, PMID 37698477, PMID 37777947, PMID 37908552, PMID 38469689, PMID 38483246, PMID 38583086, PMID 38714459, PMID 38939381, PMID 39895494, PMID 39895495, PMID 40818667, PMID 40983565, PMID 41068029, PMID 41817483
1ZIAHL006242-02 (1), 2019 (1), 2025 (1)